Tech-Based Caregiver Support for Alzheimer's Disease
(TACAD Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that internet-based support services for Asian American caregivers, like the one developed for Chinese caregivers, are feasible and can improve caregivers' knowledge and self-efficacy in seeking support. Additionally, a pilot intervention for Vietnamese American caregivers was well-received and led to increased Alzheimer's knowledge and confidence in accessing support services.
12345The studies reviewed focus on the feasibility and acceptability of caregiver interventions, but they do not provide specific safety data for the tech-based caregiver support. However, caregivers who participated in these interventions found them informative and engaging, suggesting they were generally well-received.
23678TACAD is unique because it is a technology-based program specifically designed to support Asian American midlife women who are family caregivers of Alzheimer's patients, focusing on culturally-responsive education and coaching to help them manage the complex and unpredictable nature of the disease.
2391011Eligibility Criteria
This trial is for Asian American women, aged 40-65, who are Chinese or Korean and care for family members with early to middle-stage Alzheimer's. They must read/write English, Mandarin, or Korean, live in the U.S., have internet access, and provide at least 4 hours of daily unpaid care without plans for institutionalizing the patient within six months.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a technology-based program for 3 months, with weekly group and individual coaching/support for the intervention group.
Follow-up
Participants are monitored for changes in caregiver and care recipient outcomes through Internet surveys.